Zefen Xiao Selected Research

Zefen Xiao Research Topics

40	Esophageal Squamous Cell Carcinoma 01/2023 - 12/2011
22	Neoplasms (Cancer) 01/2023 - 12/2008
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2011
19	Esophageal Neoplasms (Esophageal Cancer) 11/2023 - 12/2011
6	Carcinoma (Carcinomatosis) 01/2022 - 11/2002
6	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2021 - 11/2002
5	Radiation Pneumonitis 01/2022 - 10/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2011
4	Lymphatic Metastasis 02/2020 - 10/2013
4	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2011
3	Margins of Excision 11/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2005
2	Thymoma (Thymic Carcinoma) 10/2021 - 08/2013
2	Brain Neoplasms (Brain Tumor) 01/2019 - 06/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2017 - 03/2015
2	Esophagitis 06/2015 - 10/2005
1	Carcinosarcoma 10/2022
1	Seminoma 03/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Thymus Neoplasms (Thymus Neoplasm) 10/2021
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 10/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2021
1	Residual Neoplasm 09/2020
1	Pathologic Complete Response 02/2020
1	Adenocarcinoma 12/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2015
1	Weight Loss (Weight Reduction) 10/2005
1	Pathologic Constriction (Stenosis) 11/2002

6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 08/2018 - 06/2014
2	SurvivinIBA 01/2018 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2013
2	B7-H1 AntigenIBA 04/2017 - 01/2017
1	nimotuzumabIBA 01/2023
1	tislelizumabIBA 11/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2019
1	Celecoxib (Celebrex)FDA Link 12/2019
1	AntigensIBA 08/2018
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2018
1	antigen CYFRA21.1IBA 08/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	sepantroniumIBA 01/2018
1	ORALIT (ORS)IBA 06/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2014
1	Caspase 3 (Caspase-3)IBA 10/2013
1	Matrix Metalloproteinases (MMPs)IBA 10/2013
1	Proline (L-Proline)FDA Link 10/2013
1	Phenobarbital (Luminal)FDA Link 12/2010

51	Radiotherapy 11/2023 - 11/2002
21	Chemoradiotherapy 01/2023 - 03/2015
12	Drug Therapy (Chemotherapy) 01/2023 - 10/2005
11	Esophagectomy 11/2022 - 12/2008
10	Therapeutics 01/2023 - 01/2015
10	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2022 - 01/2015
6	Neoadjuvant Therapy 01/2022 - 07/2015
6	Conformal Radiotherapy 05/2021 - 10/2005
5	Adjuvant Radiotherapy 03/2022 - 08/2013
3	Adjuvant Chemotherapy 08/2021 - 05/2019
2	Immunotherapy 01/2023 - 01/2023
1	Palliative Care (Palliative Therapy) 09/2020
1	Salvage Therapy 02/2020
1	Consolidation Chemotherapy 01/2020
1	Pneumonectomy (Lung Volume Reduction) 05/2019
1	Aftercare (After-Treatment) 01/2019
1	Combined Modality Therapy 01/2019
1	Brachytherapy 12/2010